Skip to main content

Advertisement

Log in

Congenital Heart Disease in the Adult: What Should the Adult Cardiologist Know?

  • Echocardiography (JM Gardin, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

There is an increasing population of adults with congenital heart disease (CHD) due to successful pediatric medical and surgical intervention, and commensurate with this increase is a rise in heart failure, hospital admissions, and hospital costs among adult CHD patients. This group of patients requires careful long-term evaluation and follow-up of the residua and sequelae of their cardiac anomalies that arise in adulthood to prevent late complications. This article addresses congenital heart defects that are encountered in a general adult cardiology practice and reviews clinical, anatomic, and imaging features of each lesion, fundamental management issues, indications for interventions (and often re-interventions), issues related to endocarditis prophylaxis, pregnancy, and appropriateness of referral to a dedicated adult CHD program for long-term care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13

Similar content being viewed by others

Abbreviations

2D:

Two-dimensional

3D:

Three-dimensional

ASD:

Atrial septal defect

AVSD:

Atrioventricular septal defects

BAV:

Bicuspid aortic valve

CCTGA:

Congenitally corrected transposition of the great arteries

CHD:

Congenital heart disease

CMR:

Cardiac magnetic resonance imaging

CW:

Continuous wave

DCRV:

Double chamber right ventricle

D-TGA:

D-transposition of the great arteries

IVC:

Inferior vena cava

LV:

Left ventricle

PA:

Pulmonary artery

PDA:

Patent ductus arteriosus

PFO:

Patent foramen ovale

PR:

Pulmonic regurgitation

PS:

Pulmonic stenosis

PV:

Pulmonic valve

PW:

Pulsed wave

RV:

Right ventricle

RVOT:

Right ventricular outflow tract

SVC:

Superior vena cava

TOF:

Tetralogy of Fallot

TR:

Tricuspid regurgitation

VSD:

Ventricular septal defect

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Van Der Bom T, Bouma BJ, Meijboom FJ, et al. The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation. Am Heart J. 2012;164:568–75.

    Article  PubMed  Google Scholar 

  2. Marelli AJ, Mackie AS, Ionescu-Ittu R, et al. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115:163–72.

    Article  PubMed  Google Scholar 

  3. Billett J, Cowie MR, Gatzoulis MA, et al. Comorbidity, healthcare utilisation and process of care measures in patients with congenital heart disease in the UK: cross-sectional, population-based study with case–control analysis. Heart. 2008;94:1194–9.

    Article  CAS  PubMed  Google Scholar 

  4. Van Der Velde ET, Vriend JW, Mannens MM, et al. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur J Epidemiol. 2005;20:549–57.

    Article  PubMed  Google Scholar 

  5. Rodriguez FH, 3rd Marelli AJ. The epidemiology of heart failure in adults with congenital heart disease. Heart Fail Clin. 2014;10:1–7. His article reviews the rapid rise in the incidence of clinical heart failure among various congenital heart defects.

    Article  PubMed  Google Scholar 

  6. O’Leary JM, Siddiqi OK, Et Al DFS. The changing demographics of congenital heart disease hospitalizations in the United States, 1998 through 2010. JAMA. 2013;309:984–6. This letter describes a very important rise in hospital admissions related to congenital heart defects comparing children and adults (>18 Years), and demonstrates a more rapid rate of rise of admissions related to adult CHD.

    Article  PubMed  Google Scholar 

  7. Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the US. J Am College Cardiol. 2009;54:460–7.

    Article  Google Scholar 

  8. Bauer M, Pasic M, Meyer R, et al. Morphometric analysis of aortic media in patients with bicuspid and tricuspid aortic valve. Ann Thorac Surg. 2002;74:58–62.

    Article  PubMed  Google Scholar 

  9. Nataatmadja M, West M, West J, et al. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation. 2003;108 Suppl 1:II329–34.

    PubMed  Google Scholar 

  10. Michelena HI, Khanna AD, Mahoney D, et al. Incidence of aortic complications in patients with bicuspid aortic valves. JAMA. 2011;306:1104–12.

    Article  CAS  PubMed  Google Scholar 

  11. Fedak PW, Verma S, David TE, et al. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation. 2002;106:900–4.

    Article  PubMed  Google Scholar 

  12. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008;118:E714–833.

    Article  PubMed  Google Scholar 

  13. Roifman I, Therrien J, Ionescu-Ittu R, et al. Coarctation of the aorta and coronary artery disease: fact or fiction? Circulation. 2012;126:16–21.

    Article  PubMed  Google Scholar 

  14. Graham Jr TP, Driscoll DJ, Gersony WM, et al. Task force 2: congenital heart disease. J Am College Cardiol. 2005;45:1326–33.

    Article  Google Scholar 

  15. Oosterhof T, Van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of fallot using cardiovascular magnetic resonance. Circulation. 2007;116:545–51.

    Article  PubMed  Google Scholar 

  16. Renella P, Aboulhosn J, Lohan DG, et al. Two-dimensional and Doppler echocardiography reliably predict severe pulmonary regurgitation as quantified by cardiac magnetic resonance. J Am Soc Echocardiography : Off Publ Am Soc Echocardiography. 2010;23:880–6.

    Article  Google Scholar 

  17. Valente AM, Cook S, Et Al FP. Multimodality imaging guidelines for patients with repaired Tetralogy of Fallot: a report from the american society of echocardiography: developed in collaboration with the society for cardiovascular magnetic resonance and the society for pediatric radiology. J Am Soc Echocardiography : Off Pub Am Soc Echocardiography. 2014;27:111–41. Updated review of all imaging modalities available for assessment of Tetralogy of Fallot including indications and limitation.

    Article  Google Scholar 

  18. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in Tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92:231–7.

    Article  CAS  PubMed  Google Scholar 

  19. Valente AM, Gauvreau K, Assenza GE, et al. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of fallot enrolled in the indicator cohort. Heart. 2014;100:247–53.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Gurvitz M, Marelli A, Mangione-Smith R, Jenkins K. Building quality indicators to improve care for adults with congenital heart disease. J Am College Cardiol. 2013;62:2244–53.

    Article  Google Scholar 

  21. Apitz C, Webb GD, Redington AN. Tetralogy of Fallot. Lancet. 2009;374:1462–71.

    Article  CAS  PubMed  Google Scholar 

  22. Eicken A, Ewert P, Hager A, et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J. 2011;32:1260–5.

    Article  PubMed  Google Scholar 

  23. Gillespie MJ, Rome JJ, Levi DS Et A. Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv. 2012;5:862–70. Multicenter study evlauating the use of transcatheter pulmonic valve placement within a prior failed bioprosthetic pulmonic valve demonstrating favorable results.

    Article  PubMed  Google Scholar 

  24. Inglessis I, Landzberg MJ. Interventional catheterization in adult congenital heart disease. Circulation. 2007;115:1622–33.

    Article  PubMed  Google Scholar 

  25. Van Der Bom T, Winter MM, Bouma BJ, et al. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation. 2013;127:322–30.

    Article  PubMed  Google Scholar 

  26. Warnes CA. Transposition of the great arteries. Circulation. 2006;114:2699–709.

    Article  PubMed  Google Scholar 

  27. Bharati S, Mccue CM, Tingelstad JB, et al. Lack of connection between the atria and the peripheral conduction system in a case of corrected transposition with congenital atrioventricular block. Am J Cardiol. 1978;42:147–53.

    Article  CAS  PubMed  Google Scholar 

  28. Huhta JC, Maloney JD, Ritter DG, et al. Complete atrioventricular block in patients with atrioventricular discordance. Circulation. 1983;67:1374–7.

    Article  CAS  PubMed  Google Scholar 

  29. Biliciler-Denktas G, Feldt RH, Connolly HM, et al. Early and late results of operations for defects associated with corrected transposition and other anomalies with atrioventricular discordance in a pediatric population. J Thorac Cardiovasc Surg. 2001;122:234–41.

    Article  CAS  PubMed  Google Scholar 

  30. Scherptong RW, Vliegen HW, Winter MM, et al. Tricuspid valve surgery in adults with a dysfunctional systemic right ventricle: repair or replace? Circulation. 2009;119:1467–72.

    Article  PubMed  Google Scholar 

  31. Mauri L, Foster E, Glower DD, et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am College Cardiol. 2013;62:317–28.

    Article  Google Scholar 

  32. Franzen O, Von Samson P, Dodge-Khatami A, et al. Percutaneous edge-to-edge repair of tricuspid regurgitation in congenitally corrected transposition of the great arteries. Congenit Heart Dis. 2011;6:57–9.

    Article  PubMed  Google Scholar 

  33. Murtuza B, Barron DJ, Stumper O, et al. Anatomic repair for congenitally corrected transposition of the great arteries: a single-institution 19-year experience. J Thorac Cardiovasc Surg. 2011;142:1348–57.

    Article  PubMed  Google Scholar 

  34. Duncan BW, Mee RB, Prieto LR, et al. Staged repair of tetralogy of fallot with pulmonary atresia and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg. 2003;126:694–702.

    Article  PubMed  Google Scholar 

  35. Jategaonkar SR, Scholtz W, Horstkotte D, et al. Interventional closure of atrial septal defects in adult patients with Ebstein’s anomaly. Congenit Heart Dis. 2011;6:374–81.

    Article  PubMed  Google Scholar 

  36. Roberts PA, Boudjemline Y, Cheatham JP, et al. Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J Am College Cardiol. 2011;58:117–22.

    Article  Google Scholar 

  37. Benavidez OJ, Connor JA, Gauvreau K, Jenkins KJ. The contribution of complications to high resource utilization during congenital heart surgery admissions. Congenit Heart Dis. 2007;2:319–26.

    Article  PubMed  Google Scholar 

  38. Kim YY, Gauvreau K, Bacha EA, et al. Resource use among adult congenital heart surgery admissions in pediatric hospitals: risk factors for high resource utilization and association with inpatient death. Circ Cardiovasc Qual Outcomes. 2011;4:634–9.

    Article  PubMed  Google Scholar 

  39. Davies RR, Chen JM, Mosca RS. The fontan procedure: evolution in technique; attendant imperfections and transplantation for “failure”. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2011;14:55–66.

    Article  PubMed  Google Scholar 

  40. Goldberg DJ, Shaddy RE, Ravishankar C, Rychik J. The failing fontan: etiology, diagnosis and management. Expert Rev Cardiovasc Ther. 2011;9:785–93.

    Article  PubMed  Google Scholar 

  41. Castillo JC, Anguita MP, Ramirez A, et al. Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study. Heart. 2000;83:525–30.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American heart association: a guideline from the american heart association rheumatic fever, endocarditis, and Kawasaki disease committee, council on cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation. 2007;116:1736–54.

    Article  PubMed  Google Scholar 

  43. Verheugt CL, Uiterwaal CS, Van Der Velde ET, et al. Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population. Eur Heart J. 2011;32:1926–34.

    Article  PubMed  Google Scholar 

  44. Stout K. Pregnancy in women with congenital heart disease: the importance of evaluation and counselling. Heart. 2005;91:713–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Uebing A, Steer PJ, Yentis SM, Gatzoulis MA. Pregnancy and congenital heart disease. BMJ. 2006;332:401–6.

    Article  PubMed Central  PubMed  Google Scholar 

  46. Vitarelli A, Capotosto L. Role of echocardiography in the assessment and management of adult congenital heart disease in pregnancy. Int J Cardiovasc Imaging. 2011;27:843–57.

    Article  PubMed  Google Scholar 

  47. Gaggin HK, Januzzi JL. Chapter 21: MGH Cardiology Board Review Book. Springer, 2014.

  48. Otto CM, editor. Practice of clinical echocardiography. 4th ed. Philadelphia: Elsevier/Saunders; 2012.

    Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Doreen DeFaria Yeh and Mary Etta King declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Doreen DeFaria Yeh.

Additional information

This article is part of the Topical Collection on Echocardiography

Electronic supplementary material

Below is the link to the electronic supplementary material.

AVI video of parasternal short-axis view of young adult with a unicuspid AV. Note the “keyhole” appearance with an open commissure between the non and left coronary cusps, and two raphe. (AVI 15433 kb)

AVI video of the apical four-chamber view in a patient with Ebstein’s anomaly of the tricuspid valve. The left image shows the tethering and apical displacement of the tricuspid valve leaflets with dilated right atrium and atrialized RV. The color Doppler image on the right shows severe TR. (AVI 26911 kb)

AVI video of the apical four-chamber view in a patient with tricuspid atresia post fenestrated lateral tunnel Fontan palliation. At the tricuspid annulus is a fibrous band of tissue, and the right ventricle is hypoplastic. The Fontan pathway through the atrium is seen as a circular structure within the right atrium. (AVI 1242 kb)

AVI video of the color Doppler apical four-chamber view in the same patient showing the flow through the fenestration in the atrial baffle as a small jet entering the common atrium. (AVI 1816 kb)

Appendices

Appendix 1. Echocardiographic Essentials for Assessment of Left and Right Heart Obstruction

Bicuspid Aortic Valve:

  1. 1.

    Morphologic aortic valve features, location of commissural fusion and opening

  2. 2.

    Degree of stenosis and regurgitation

  3. 3.

    Estimated aortic valve area

  4. 4.

    Dimensions of the aortic annulus, sinuses of Valsalva, and ascending aorta

  5. 5.

    LV size, mass, and function

  6. 6.

    Associated left sided obstructive lesions including coarctation, subaortic stenosis, and supramitral ring, additionally ASDs, VSDs and mitral abnormalities

Discrete Subaortic Stenosis:

  1. 1.

    The nature and location of the membrane

  2. 2.

    The degree of LVOT obstruction and aortic valvular regurgitation

  3. 3.

    Aortic annular dimension and aortic valve morphology

  4. 4.

    LV size, mass, and function.

  5. 5.

    Associated defects such as membranous VSD and DCRV

Aortic Coarctation (native or recurrent coarctation):

  1. 1.

    Aortic annulus, sinuses, ascending aorta, transverse arch, isthmus, and descending thoracic aortic dimensions

  2. 2.

    Brachiocephalic branch anatomy

  3. 3.

    Pulsed wave (PW), continuous wave (CW) and color Doppler sampling of the transverse and descending thoracic aorta

  4. 4.

    Pulsed Doppler sampling of the abdominal aorta

  5. 5.

    LV size, mass, and function

  6. 6.

    Aortic valve anatomy and function

  7. 7.

    Associated lesions such as VSD, subaortic membrane, BAV and mitral valve anomalies (mitral prolapse, parachute mitral valve, supramitral ring, aberrant papillary muscle arrangement), aortic arch abnormalities and aberrant subclavian arteries

Valvular PS:

  1. 1.

    Pulmonary valve leaflet morphology and thickness

  2. 2.

    Annular, main PA, and branch dimensions

  3. 3.

    CW Doppler peak and mean gradient

  4. 4.

    Degree of regurgitation

  5. 5.

    Subvalvular hypertrophy or obstruction

  6. 6.

    RV size, wall thickness, and function

  7. 7.

    Doppler TR peak velocity

  8. 8.

    Associated ASD, PFO, VSD, other RV outflow obstruction

Infundibular PS:

  1. 1.

    2D imaging of the mid and distal RV outflow tract in parasternal and subcostal views

  2. 2.

    Color and PW/CW Doppler sampling of the RV outflow tract proximal to the pulmonic valve

  3. 3.

    Pulmonary valve morphology

  4. 4.

    Doppler TR peak velocity

Appendix 2. Echocardiographic Essentials for Evaluation of Congenital Shunt Lesions

Atrial septal defects (native or preprocedural imaging):

  1. 1.

    ASD size and location from multiple windows

  2. 2.

    Septal rims

  3. 3.

    RV size and function

  4. 4.

    Estimated RV and PA pressure from TR and PR jet velocity

  5. 5.

    Associated lesions—PS, mitral valve prolapse, cleft mitral valve, anomalous pulmonary veins, persistent left SVC

Postoperative ASD assessment:

  1. 1.

    Residual shunting

  2. 2.

    Residual pulmonary hypertension

  3. 3.

    RV enlargement and dysfunction

  4. 4.

    RV or RA thrombus

  5. 5.

    Mitral regurgitation from cleft MV or mitral valve prolapse

  6. 6.

    SVC or pulmonary vein stenosis after sinus venosus ASD repair

Post device closure ASD assessment:

  1. 1.

    Device position

  2. 2.

    Residual shunting

  3. 3.

    Device impingement upon systemic or pulmonary venous inflow

  4. 4.

    Device impairment of aortic, mitral or tricuspid valve function

  5. 5.

    Device impingement upon posterior aortic wall

  6. 6.

    Thrombus or vegetation on right or left atrial device facets

Native Ventricular Septal Defect:

  1. 1.

    Size and location of VSD

  2. 2.

    Direction of shunt flow; LV to RV shunting, LV to RA shunting

  3. 3.

    LA size

  4. 4.

    LV size, mass, and function

  5. 5.

    VSD gradient by CW Doppler

  6. 6.

    Estimated RV and PA pressure from TR and PR velocities

  7. 7.

    Presence and degree of RVOT obstruction—DCRV, infundibular, valvar, or branch PS

  8. 8.

    Associated lesions—membranous septal aneurysm, aortic valve prolapse, or discrete subaortic membrane

VSD: Following surgical repair:

  1. 1.

    Residual VSD shunt

  2. 2.

    Residual pulmonary hypertension

  3. 3.

    LV dysfunction

  4. 4.

    TR due to surgical distortion of the septal leaflet

  5. 5.

    Aortic valve prolapse with aortic insufficiency

  6. 6.

    Aortic valve distortion and dysfunction due to VSD patch placement

  7. 7.

    Discrete subaortic membrane and DCRV

Unrepaired Atrioventricular Septal Defect:

  1. 1.

    Size and location of atrial and ventricular defects

  2. 2.

    Presence, direction, and size of ASD and VSD shunt

  3. 3.

    Estimate of RV and PA pressure from TR and PR velocities

  4. 4.

    Specifics of atrioventricular valve anatomy—common AV valve, septal attachments of anterior and posterior bridging leaflets (Rastelli Type A, B, or C); unbalanced alignment

  5. 5.

    Degree of left or right AV valve regurgitation

  6. 6.

    Papillary muscle anatomy and chordal attachments

  7. 7.

    LV size, mass, and function

  8. 8.

    RV size, wall thickness, and function

  9. 9.

    Associated defects—PDA, coarctation, subaortic obstruction

Postoperative AVSD:

  1. 1.

    Residual atrial or ventricular shunt; possible LV-right atrial shunting

  2. 2.

    Residual pulmonary hypertension

  3. 3.

    AV valve regurgitation

  4. 4.

    Discrete subaortic stenosis

  5. 5.

    Assessment of other co-existing preoperative issues

PDA pre- and postintervention:

  1. 1.

    Size and shape of the ductal channel

  2. 2.

    Size and direction of shunt,

  3. 3.

    Aortopulmonary gradient from peak systolic PDA jet velocity

  4. 4.

    LA and LV chamber size; LV function

  5. 5.

    Main PA and branch PA dimensions

  6. 6.

    Aortic arch and isthmus anatomy

  7. 7.

    Device or coil position with specific attention to residual shunt, branch PA stenosis or aortic protrusion

Appendix 3. Echocardiographic Essentials for Assessment of Complex Congenital Heart Disease

Unoperated patient with TOF:

  1. 1.

    VSD location, size and shunt direction; additional VSDs

  2. 2.

    Degree and nature of RV outflow tract obstruction

  3. 3.

    RVOT and branch PA gradients

  4. 4.

    Pulmonary annulus, main and branch PA dimensions

  5. 5.

    RV size, wall thickness, and quantitative assessment of function

  6. 6.

    Coronary artery origins and course

  7. 7.

    Atrial septal anatomy

  8. 8.

    Aortic arch situs

  9. 9.

    Aortopulmonary collaterals

Postoperative patient with TOF:

  1. 1.

    Residual VSD

  2. 2.

    Residual infundibular, valvular or branch PS; DCRV

  3. 3.

    Degree of PR (CW across RV outflow tract)

  4. 4.

    Residual atrial shunting

  5. 5.

    RV volumes, quantitative systolic, and diastolic function

  6. 6.

    Estimated RV pressure from Doppler peak TR jet velocity

  7. 7.

    Aortic valve anatomy and function

  8. 8.

    Aortic root dimensions

  9. 9.

    LV size, global and segmental function

  10. 10.

    Conduit location, size, and gradients, if present

  11. 11.

    Prosthetic pulmonic valve (PV) stenosis or regurgitation, if present

D-Transposition of the Great Arteries after Mustard or Senning procedure (atrial switch):

  1. 1.

    Systemic RV size and function

  2. 2.

    Subaortic and aortic stenosis

  3. 3.

    Subpulmonary LVOT obstruction

  4. 4.

    Estimated subpulmonary ventricular pressure from mitral valve regurgitant velocity

  5. 5.

    Tricuspid valve (systemic AV valve) regurgitation

  6. 6.

    Baffle pathway obstruction

  7. 7.

    Baffle leak (consider agitated saline study if leak not obviously present by Doppler)

  8. 8.

    Associated lesions—VSD, valvar or branch PS, PDA, coarctation

Postarterial switch operation for D-TGA:

  1. 1.

    Aortic root, supravalvar aortic dimensions, and gradient

  2. 2.

    Neo-aortic valve regurgitation

  3. 3.

    Neo-pulmonic valve function

  4. 4.

    Suprapulmonary stenosis in MPA or branches

  5. 5.

    LV size, mass, global and segmental function

  6. 6.

    RV size, wall thickness and function

  7. 7.

    Proximal coronary artery patency

  8. 8.

    Associated lesions—VSD, coarctation

Congenitally Corrected Transposition of the Great Arteries (CCTGA):

  1. 1.

    Identification of visceroatrial situs

  2. 2.

    Establishment of cardiac position—levo-, meso-, or dextrocardia

  3. 3.

    Demonstration of atrioventricular and ventriculoarterial discordance (RA-LV-PA; LA-RV-Aorta)

  4. 4.

    Location, size, and direction of VSD shunt if present

  5. 5.

    Nature and degree of PS or subpulmonary outflow obstruction

  6. 6.

    Anatomy and function of tricuspid valve (systemic AV valve)

  7. 7.

    Size and function of the RV (systemic ventricle)

  8. 8.

    Coronary artery anatomy

Postoperative patient with CCTGA:

  1. 1.

    Biventricular size and function

  2. 2.

    Residual VSD

  3. 3.

    Residual RV or LV outflow obstruction

  4. 4.

    Degree of TR

  5. 5.

    Atrial baffles if present

  6. 6.

    Great artery anastomoses if present

  7. 7.

    Conduit function if present

  8. 8.

    Neo-aortic size and insufficiency

  9. 9.

    Coronary artery patency if translocated

Ebstein’s anomaly:

  1. 1.

    Tricuspid leaflet origin, position, size and tethering

  2. 2.

    Degree of TR

  3. 3.

    RA and atrialized RV size and function

  4. 4.

    True RV size and function

  5. 5.

    Pulmonary valve stenosis

  6. 6.

    Main and branch PA dimensions

  7. 7.

    Atrial septal communication and shunt direction

  8. 8.

    LV size and function

Postoperative Ebstein’s anomaly:

  1. 1.

    Anatomic assessment of tricuspid valve repair or replacement

  2. 2.

    Degree of TR, presence of paravalvular leaking

  3. 3.

    RA size

  4. 4.

    RV size and function

  5. 5.

    LV size and function

  6. 6.

    Patency of Glenn shunt if present

  7. 7.

    Patency of Fontan pathway if present

  8. 8.

    ASD device position and residual shunt if present

Complex CHD: must be individualized to the specific lesion but includes the following basic features:

  1. 1.

    Visceroatrial situs—solitus, inversus, indeterminate

  2. 2.

    Cardiac position—levocardia, mesocardia, dextrocardia

  3. 3.

    Number of atrial chambers and morphology

  4. 4.

    Number of ventricular chambers and morphology

  5. 5.

    Atrioventricular relationship

  6. 6.

    Number of great arteries and their relationship

  7. 7.

    Ventriculoarterial relationship

  8. 8.

    Intracardiac shunts

  9. 9.

    Outflow tract obstruction

  10. 10.

    Other associated anomalies—coarctation, branch PS, systemic and pulmonary venous abnormalities

Complex CHD following the Fontan procedure:

  1. 1.

    Inferior vena cava (IVC) and SVC size and flow pattern

  2. 2.

    Right atrial size

  3. 3.

    Right atrial to PA anastomosis patency and flow patterns, if present

  4. 4.

    Interatrial or extracardiac venous conduit flow patterns

  5. 5.

    Branch PA size and flow pattern

  6. 6.

    Thrombus within the systemic venous pathway

  7. 7.

    Baffle fenestration flow and Doppler gradient

  8. 8.

    Pulmonary venous inflow and left atrial size

  9. 9.

    Atrioventricular valve function

  10. 10.

    Systemic ventricular size and function

  11. 11.

    Outflow tract obstruction

  12. 12.

    Aortic valve stenosis or incompetence

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

DeFaria Yeh, D., King, M.E. Congenital Heart Disease in the Adult: What Should the Adult Cardiologist Know?. Curr Cardiol Rep 17, 25 (2015). https://doi.org/10.1007/s11886-015-0579-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-015-0579-7

Keywords

Navigation